Income Taxes |
9 Months Ended |
|---|---|
Sep. 30, 2026 | |
| Income Tax Disclosure [Abstract] | |
| Income Taxes | Income Taxes The Company had no income tax benefit or expense during the three months ended September 30, 2026, the nine months ended September 30, 2026, the period from September 12, 2025 to September 30, 2025, the period from July 1, 2025 to September 11, 2025, or the period from January 1, 2025 to September 11, 2025, which resulted in an effective tax rate of zero for each period. The Company's effective tax rate differs from the U.S. federal corporate statutory rate of 21.0% primarily due to the Company's net loss from operations and unrealized gains, which resulted in a net taxable loss for each period. The Company did not recognize any net deferred tax asset as of September 30, 2026 and December 31, 2025 due to the establishment of a full valuation allowance. Internal Revenue Code ("IRC") Section 382 addresses company ownership changes and specifically limits the utilization of certain deductions and tax attributes on an annual basis. As a result of the Asset Entities Merger and Semler Scientific Merger, the Company's tax attributes, including net operating losses, may be subject to IRC Section 382 limitations.
|